Cost of Illness < Cost-Benefit Analysis < Costs and Cost Analysis

Facettes : Author.f

List of bibliographic references

Number of relevant bibliographic references: 27.
[0-20] [0 - 20][0 - 27][20-26][20-40]

Ident.	Authors (with country if any)	Title
000028 (2019)	Andrew J. Leidner ; Neil Murthy ; Harrell W. Chesson ; Matthew Biggerstaff ; Charles Stoecker ; Aaron M. Harris ; Anna Acosta ; Kathleen Dooling ; Carolyn B. Bridges	Cost-effectiveness of adult vaccinations: A systematic review.
000098 (2017)	Eon E K. Ting ; Beate Sander ; Wendy J. Ungar	Systematic review of the cost-effectiveness of influenza immunization programs.
000117 (2017)	Edward W. Thommes ; Morgan Kruse ; Michele Kohli ; Rohita Sharma ; Stephen G. Noorduyn	Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines.
000119 (2016)	Corwin A. Robertson ; Carlos A. Diazgranados ; Michael D. Decker ; Ayman Chit ; Monica Mercer ; David P. Greenberg	Fluzone® High-Dose Influenza Vaccine.
000127 (2016)	Debbie L. Becker ; Ayman Chit ; Carlos A. Diazgranados ; Michael Maschio ; Eddy Yau ; Michael Drummond	High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors.
000167 (2016)	Léon Nshimyumukiza ; Xavier Douville ; Diane Fournier ; Julie Duplantie ; Rana K. Daher ; Isabelle Charlebois ; Jean Longtin ; Jesse Papenburg ; Maryse Guay ; Maurice Boissinot ; Michel G. Bergeron ; Denis Boudreau ; Christian Gagné ; François Rousseau ; Daniel Reinharz	Cost-effectiveness analysis of antiviral treatment in the management of seasonal influenza A: point-of-care rapid test versus clinical judgment.
000173 (2015)	Edward W. Thommes ; Afisi Ismaila ; Ayman Chit ; Genevieve Meier ; Christopher T. Bauch	Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.
000196 (2015)	Ayman Chit ; Julie Roiz ; Samuel Aballea	An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model.
000225 (2015)	P G Van Buynder ; S. Konrad ; F. Kersteins ; E. Preston ; P D Brown ; D. Keen ; N J Murray	Healthcare worker influenza immunization vaccinate or mask policy: strategies for cost effective implementation and subsequent reductions in staff absenteeism due to illness.
000227 (2015)	Alison K. Thompson ; Maxwell J. Smith ; Christopher W. Mcdougall ; Cécile Bensimon ; Daniel Felipe Perez	"With human health it's a global thing": Canadian perspectives on ethics in the global governance of an influenza pandemic.
000243 (2014)	Meghann Gregg ; Gordon Blackhouse ; Mark Loeb ; Ron Goeree	Economic evaluation of an influenza immunization strategy of healthy children.
000440 (2012)	Stephanie R. Earnshaw ; Cheryl L. Mcdade ; Giovanni Zanotti ; Raymond A. Farkouh ; David Strutton	Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada.
000471 (????)	Chris Skedgel ; Joanne M. Langley ; Noni E. Macdonald ; Jeff Scott ; Shelly Mcneil	An incremental economic evaluation of targeted and universal influenza vaccination in pregnant women.
000472 (2011)	Bohdan Nosyk ; Behnam Sharif ; Huiying Sun ; Curtis Cooper ; Aslam H. Anis	The cost-effectiveness and value of information of three influenza vaccination dosing strategies for individuals with human immunodeficiency virus.
000476 (2011)	David N. Fisman ; Ashleigh R. Tuite	Estimation of the health impact and cost-effectiveness of influenza vaccination with enhanced effectiveness in Canada.
000504 (2011)	Jennifer A. Pereira ; Julie Foisy ; Jeffrey C. Kwong ; Christine L. Heidebrecht ; Susan Quach ; Sherman D. Quan ; Maryse Guay ; Beate Sander	A cost comparison of electronic and hybrid data collection systems in Ontario during pandemic and seasonal influenza vaccination campaigns.
000603 (2011)	Elizabeth Rolland-Harris ; Martin Tepper	Cost-effectiveness of Ontario's pandemic vaccine program.
000621 (2010)	Beate Sander ; Chris T. Bauch ; David Fisman ; Robert A. Fowler ; Jeffrey C. Kwong ; Andreas Maetzel ; Allison Mcgeer ; Janet Raboud ; Damon C. Scales ; Marija Zivkovic Gojovic ; Murray Krahn	Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience.
000654 (2010)	Beate Sander ; Jeffrey C. Kwong ; Chris T. Bauch ; Andreas Maetzel ; Allison Mcgeer ; Janet M. Raboud ; Murray Krahn	Economic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysis.
000701 (????)	Nicola J. Mercer	Cost analysis of public health influenza vaccine clinics in Ontario.
000935 (2006)	Danuta M. Skowronski ; John C. Woolcott ; S Aleina Tweed ; Robert C. Brunham ; Fawziah Marra	Potential cost-effectiveness of annual influenza immunization for infants and toddlers: experience from Canada.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i -k "Cost-Benefit Analysis" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i  \
                -Sk "Cost-Benefit Analysis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeCanadaV3
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Cost-Benefit Analysis
}}

---

This area was generated with Dilib version V0.6.35. Data generation: Tue Jul 7 13:36:58 2020. Site generation: Sat Sep 26 07:06:42 2020